Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
Cannabis
Long time readers have been aware that, for some time, Equity.Guru has been a supporter of Canntab Therapeutics (PILL.C), but have been frustrated watching the company being slow on…
We open this sector roundup with big news from China. The Chinese government is telling people to stock up on food and necessities as temperatures fall and Covid-19 cases…
Last week, I was asked at least a dozen times by market professionals, “What sector do you like right now?” Normally that’s an easy question to ask as there’s…
Revive Therapeutics (“RVV.C”) is a life sciences company that focuses on the research and development of therapeutics for rare disorders and infectious diseases. and it is prioritizing drug development…
Revive Therapeutics (RVV.C) is an interesting play. You like cannabis and its health benefits? Revive Therapeutics is one to add on your list. Maybe you are more bullish Psychedelics?…
Business Overview Canntab Therapeutics is a Canadian biopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations….
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
Canntab Therapeutics (PILL.CN) is a Canadian biopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. Canntab’s…
Canntab Therapeutics (PILL.C) has been around the block and then some. The Ontario-based pharmaceutical answer to medicinal cannabis, has pioneered a patented process to turn CBD, THC and terpene…